Condensed Consolidated Statements of Changes in Stockholders’ Equity (unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Mar. 31, 2022		53,379,307
Beginning balance at Mar. 31, 2022	$ 31,361	$ 5	$ 211,190	$ (178,638)	$ (1,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)		13,422
Stock options exercised	56		56
Restricted stock units vested (in shares)		35,180
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(1,568)
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability	(6)		(6)
Issuance of common stock, net of issuance costs (in shares)		3,199,999
Issuance of common stock, net of issuance costs	15,720	$ 1	15,719
Stock-based compensation	1,219		1,219
Other comprehensive loss	(657)				(657)
Net income (Loss)	(11,348)			(11,348)
Ending balance (in shares) at Sep. 30, 2022		56,626,340
Ending balance at Sep. 30, 2022	36,345	$ 6	228,178	(189,986)	(1,853)
Beginning balance (in shares) at Mar. 31, 2022		53,379,307
Beginning balance at Mar. 31, 2022	31,361	$ 5	211,190	(178,638)	(1,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income (Loss)	$ (30,600)
Ending balance (in shares) at Mar. 31, 2023	57,047,013	57,047,013
Ending balance at Mar. 31, 2023	$ 19,615	$ 6	230,272	(209,236)	(1,427)
Beginning balance (in shares) at Jun. 30, 2022		56,588,042
Beginning balance at Jun. 30, 2022	41,938	$ 6	227,512	(183,991)	(1,589)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock options exercised (in shares)		9,061
Stock options exercised	36		36
Restricted stock units vested (in shares)		30,805
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(1,568)
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability	(6)		(6)
Stock-based compensation	636		636
Other comprehensive loss	(264)				(264)
Net income (Loss)	(5,995)			(5,995)
Ending balance (in shares) at Sep. 30, 2022		56,626,340
Ending balance at Sep. 30, 2022	$ 36,345	$ 6	228,178	(189,986)	(1,853)
Beginning balance (in shares) at Mar. 31, 2023	57,047,013	57,047,013
Beginning balance at Mar. 31, 2023	$ 19,615	$ 6	230,272	(209,236)	(1,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)		299,560
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(86,045)
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability	(288)		(288)
Stock warrant exercise and deemed dividend related to warrant modification, net of issuance costs (Note 8) (in shares)		1,815,848
Stock warrant exercise and deemed dividend related to warrant modification, net of issuance costs (Note 8)	7,168		7,921	(753)
Deemed dividend related to issuance of Inducement Warrants (Note 8)	0		4,859	(4,859)
Issuance of common stock, net of issuance costs (in shares)		2,904,758
Issuance of common stock, net of issuance costs	9,569	$ 0	9,569
Stock-based compensation	2,916		2,916
Other comprehensive loss	(713)				(713)
Net income (Loss)	$ (14,576)			(14,576)
Ending balance (in shares) at Sep. 30, 2023	61,981,134	61,981,134
Ending balance at Sep. 30, 2023	$ 23,691	$ 6	255,249	(229,424)	(2,140)
Beginning balance (in shares) at Jun. 30, 2023		59,374,057
Beginning balance at Jun. 30, 2023	22,824	$ 6	247,027	(222,295)	(1,914)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Restricted stock units vested (in shares)		288,115
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability (in shares)		(85,796)
Restricted stock units surrendered due to net share settlement to satisfy employee tax liability	(287)		(287)
Issuance of common stock, net of issuance costs (in shares)		2,404,758
Issuance of common stock, net of issuance costs	7,595		7,595
Stock-based compensation	914		914
Other comprehensive loss	(226)				(226)
Net income (Loss)	$ (7,129)			(7,129)
Ending balance (in shares) at Sep. 30, 2023	61,981,134	61,981,134
Ending balance at Sep. 30, 2023	$ 23,691	$ 6	$ 255,249	$ (229,424)	$ (2,140)